Adrenergic and cholinergic drugs as episode and vulnerability markers of affective disorders and schizophrenia. 1979

D S Janowsky, and J M Davis, and L Huey, and L L Judd

UI MeSH Term Description Entries
D010277 Parasympathomimetics Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. Parasympathomimetic Agents,Parasympathomimetic Drugs,Parasympathomimetic Effect,Parasympathomimetic Effects,Agents, Parasympathomimetic,Drugs, Parasympathomimetic,Effect, Parasympathomimetic,Effects, Parasympathomimetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000342 Affective Symptoms Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus. Alexithymia,Emotional Disturbances,Affective Symptom,Alexithymias,Disturbance, Emotional,Disturbances, Emotional,Emotional Disturbance,Symptom, Affective,Symptoms, Affective
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines

Related Publications

D S Janowsky, and J M Davis, and L Huey, and L L Judd
December 1976, Lancet (London, England),
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1991, Acta psychiatrica Scandinavica. Supplementum,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1983, Progress in neuro-psychopharmacology & biological psychiatry,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
March 1996, Fortschritte der Neurologie-Psychiatrie,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
August 2013, European archives of psychiatry and clinical neuroscience,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1995, Schizophrenia bulletin,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1991, Acta psychiatrica Scandinavica. Supplementum,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1985, Psychopharmacology bulletin,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
December 1972, The Journal of the American Association of Nurse Anesthetists,
D S Janowsky, and J M Davis, and L Huey, and L L Judd
January 1984, American journal of psychoanalysis,
Copied contents to your clipboard!